About Longeviti
Longeviti is a company based in Hunt Valley (United States) founded in 2014. Longeviti has raised $18.21 million across 6 funding rounds. The company has 18 employees as of December 31, 2021. Longeviti offers products and services including ClearFit OTS, ClearFit Customized, and InvisiShunt. Longeviti operates in a competitive market with competitors including CereVasc, IRRAS, Tissuemed, Aqueduct Critical Care and NeuroDx, among others.
- Headquarter Hunt Valley, United States
- Employees 18 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Longeviti Neuro Solutions, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.21 M (USD)
in 6 rounds
-
Latest Funding Round
$1.22 M (USD), Series B
Dec 30, 2024
-
Investors
Not available
-
Employee Count
18
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Longeviti
Longeviti offers a comprehensive portfolio of products and services, including ClearFit OTS, ClearFit Customized, and InvisiShunt.
Off-the-shelf implants for cranial defects with bedside imaging capabilities.
Patient-specific implants to restore cranial voids and enable ultrasound imaging.
Device to restore skull contour for patients undergoing brain surgeries.
People of Longeviti
Unlock access to complete
Unlock access to complete
Funding Insights of Longeviti
Longeviti has successfully raised a total of $18.21M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $1.22 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Longeviti
Investment portfolio details for Longeviti
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Longeviti
Detailed financials for Longeviti
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Longeviti Comparisons
Peer comparison for Longeviti
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Longeviti
Longeviti operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CereVasc, IRRAS, Tissuemed, Aqueduct Critical Care and NeuroDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
eShunt device is developed for communicating hydrocephalus treatment.
|
|
| Locked | Locked | Locked |
Provider of devices for fluid control and management after surgery
|
|
| Locked | Locked | Locked |
Bioadhesive films are developed to seal leaks in surgical procedures.
|
|
| Locked | Locked | Locked |
Novel products to manage Cerebral Spinal Fluid (CSF) pressure
|
|
| Locked | Locked | Locked |
Medical devices for assessing shunt function in hydrocephalus patient.
|
Detailed competitors of Longeviti
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Longeviti
Complete news archive for Longeviti
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Longeviti
Longeviti was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Longeviti is headquartered in Hunt Valley, United States. It is registered at Hunt Valley, Maryland, United States.
Longeviti is a funded company, having raised a total of $18.21M across 6 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Longeviti is 18.
Longeviti was founded in 2014 and is headquartered in Hunt Valley, United States. Focus is placed on the medical device sector, where implantable neurosurgical products are created. The ClearFit implant, an implantable prosthetic plate, is designed to address bony voids or defects in the cranium. Visibility of neuroanatomy and critical functional components is enabled for neurosurgeons once the device is implanted. Operations center on advancing such neurosurgical solutions.
Longeviti's top competitors include CereVasc, Tissuemed and Aqueduct Critical Care.
Longeviti offers ClearFit OTS, ClearFit Customized, and InvisiShunt.